Neuraxis (NRXS) Earnings Date & Reports

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRXS is expected to report earnings to fall 11.11% to -15 cents per share on September 17

Q2'26

Est.

$-0.16

Q1'26

Beat

by $0.04

Q4'25

Beat

by $0.06

Q3'25

Est.

$-0.24

Q2'25

Beat

by $0.03

The last earnings report on May 12 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 15.07K shares outstanding, the current market capitalization sits at 88.67M.

View a ticker or compare two or three

Compare

NRXS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NRXS